Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04467801
Title Ipatasertib and Docetaxel in Metastatic NSCLC Patients Who Have Failed 1st Line Immunotherapy (Ipat-Lung)
Acronym Ipat-Lung
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Jun Zhang, MD, PhD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST